Similar companies
| Company | Est. Net Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$74,000 |
 |
Tempus AITEM |
$160,000 |
 |
HCA HealthcareHCA |
$33,000 |
 |
ProgynyPGNY |
-$8,000 |
 |
Waters CorporationWAT |
$8,000 |
Are Members of Congress Buying or Selling Solventum?
No members of Congress have reported trading Solventum (SOLV) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the SOLV AI Score. For corporate insider activity, see SOLV insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
SOLV Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Ro Khanna | May 1, 2026 | Buy | $1K – $15K |
| Alan Armstrong | Mar 27, 2026 | Buy | $1K – $15K |
| James French Hill | Dec 31, 2025 | Sell | $15K – $50K |
| Julie Johnson | Jan 15, 2025 | Sell | $1K – $15K |
Frequently Asked Questions: Solventum Congress Trading
No members of Congress have reported buying or selling SOLV stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Ro Khanna bought Solventum (SOLV) stock most recently, on May 1, 2026.
The estimated net value of congressional trades in Solventum over the past 2 years is negative, at -$25,000, meaning members of Congress have on balance sold more than they have bought.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
